Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias.
D000818:Animals; D000914:Antibodies, Viral; D000917:Antibody Formation; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D005260:Female; D005622:Friend murine leukemia virus / Q000276:immunology*; D006023:Glycoproteins / Q000276:immunology; D007116:Immunization, Passive; D007074:Immunoglobulin G; D007165:Immunosuppression Therapy; D007942:Leukemia, Experimental / Q000628:therapy*; D008297:Male; D051379:Mice; D011925:Rauscher Virus / Q000276:immunology*; D013154:Spleen / Q000637:transplantation; D013163:Splenomegaly / Q000628:therapy; D014185:Transplantation, Isogeneic; D014764:Viral Proteins / Q000276:immunology
D000914:Antibodies, Viral; D006023:Glycoproteins; D007074:Immunoglobulin G; D014764:Viral Proteins